Literature DB >> 30772742

Sex differences in the association between thyroid-stimulating hormone levels and depressive symptoms among the general population with normal free T4 levels.

San Lee1, Sarah Soyeon Oh2, Eun-Cheol Park3, Sung-In Jang4.   

Abstract

BACKGROUND: Overt and subclinical thyroid dysfunction has been reported to be related to depression. Thyroid diseases have been known to occur more frequently in women. However, scarce data are available on effects and sex differences of changes in thyroid-stimulating hormone (TSH) levels, with a normal range of thyroid hormones, on depression. This study aimed to investigate the association between TSH levels and depressive symptoms, according to sex, in individuals from the general population with free thyroxine (fT4) values within the normal range.
METHODS: Data from the 2014 Korea National Health and Nutritional Examination Survey were used for this study. The study population of 1651 Korean adults was categorized by tertiles of TSH levels. The presence of depressive symptoms was determined using a cut-off score of 5 in the Patient Health Questionnaire-9.
RESULTS: The highest TSH tertile group was 1.92 times more likely to have depressive symptoms in men after adjustment for covariates than the lowest TSH tertile (adjusted odds ratio: 1.92, 95% confidence interval: 1.11-3.31, P = 0.019). Contrastingly, the highest TSH tertile was associated with an approximately 35% lower prevalence of depressive symptoms in women (adjusted odds ratio: 0.65, 95% confidence interval: 0.43-0.97, P = 0.034). LIMITATIONS: Cross-sectional design and unrecognized confounding factors, are the main limitations of our study.
CONCLUSIONS: Sex may play a substantial role in the relationship between TSH and depressive symptoms. Sex differences might be associated with differences in thyroid response, TSH blunting, thyroid autoimmunity, and sex hormone levels.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Depressive symptoms; Sex differences; Thyroid disease; Thyroid-stimulating hormone

Mesh:

Substances:

Year:  2019        PMID: 30772742     DOI: 10.1016/j.jad.2019.02.027

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  6 in total

1.  Increased prevalence of subclinical hypothyroidism in female hospitalized patients with depression.

Authors:  Shuai Zhao; Zhilu Chen; Xumiao Wang; Zhijian Yao; Qing Lu
Journal:  Endocrine       Date:  2020-10-16       Impact factor: 3.633

2.  Gender Discrimination in the Workplace: Effects on Pregnancy Planning and Childbirth among South Korean Women.

Authors:  Ji-Hye Kim; Sarah Soyeon Oh; Suk Won Bae; Eun-Cheol Park; Sung-In Jang
Journal:  Int J Environ Res Public Health       Date:  2019-07-26       Impact factor: 3.390

Review 3.  Depression and Autoimmune Hypothyroidism-Their Relationship and the Effects of Treating Psychiatric and Thyroid Disorders on Changes in Clinical and Biochemical Parameters Including BDNF and Other Cytokines-A Systematic Review.

Authors:  Zofia Kotkowska; Dominik Strzelecki
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-24

4.  The Prognostic Value of Thyroid-Stimulating Hormone in Patients with Coronary Artery Disease and Depression.

Authors:  Weiya Li; Di Qiu; Han Yin; Yu Wang; Yilin Chen; Quanjun Liu; Huan Ma; Qingshan Geng
Journal:  Int J Gen Med       Date:  2022-05-04

5.  Mood Disorders in Levothyroxine-Treated Hypothyroid Women.

Authors:  Benjamín Romero-Gómez; Paula Guerrero-Alonso; Juan Manuel Carmona-Torres; Blanca Notario-Pacheco; Ana Isabel Cobo-Cuenca
Journal:  Int J Environ Res Public Health       Date:  2019-11-28       Impact factor: 3.390

Review 6.  Thyroid hormone: sex-dependent role in nervous system regulation and disease.

Authors:  Shounak Baksi; Ajay Pradhan
Journal:  Biol Sex Differ       Date:  2021-03-08       Impact factor: 5.027

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.